Correlation Between Emcure Pharmaceuticals and Tribhovandas Bhimji

Can any of the company-specific risk be diversified away by investing in both Emcure Pharmaceuticals and Tribhovandas Bhimji at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emcure Pharmaceuticals and Tribhovandas Bhimji into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emcure Pharmaceuticals and Tribhovandas Bhimji Zaveri, you can compare the effects of market volatilities on Emcure Pharmaceuticals and Tribhovandas Bhimji and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emcure Pharmaceuticals with a short position of Tribhovandas Bhimji. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emcure Pharmaceuticals and Tribhovandas Bhimji.

Diversification Opportunities for Emcure Pharmaceuticals and Tribhovandas Bhimji

0.25

Correlation Coefficient

Emcure Pharmaceuticals  Tribhovandas Bhimji

Modest diversification

The 3 months correlation between Emcure and Tribhovandas is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Emcure Pharmaceuticals and Tribhovandas Bhimji Zaveri in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tribhovandas Bhimji and Emcure Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emcure Pharmaceuticals are associated (or correlated) with Tribhovandas Bhimji. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tribhovandas Bhimji has no effect on the direction of Emcure Pharmaceuticals i.e., Emcure Pharmaceuticals and Tribhovandas Bhimji go up and down completely randomly.

Pair Corralation between Emcure Pharmaceuticals and Tribhovandas Bhimji

Assuming the 90 days trading horizon Emcure Pharmaceuticals is expected to generate 0.55 times more return on investment than Tribhovandas Bhimji. However, Emcure Pharmaceuticals is 1.83 times less risky than Tribhovandas Bhimji. It trades about -0.09 of its potential returns per unit of risk. Tribhovandas Bhimji Zaveri is currently generating about -0.13 per unit of risk. If you would invest  148,110  in Emcure Pharmaceuticals on October 15, 2024 and sell it today you would lose (16,285) from holding Emcure Pharmaceuticals or give up 11.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Emcure Pharmaceuticals  vs.  Tribhovandas Bhimji Zaveri

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Tribhovandas Bhimji

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tribhovandas Bhimji Zaveri has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Emcure Pharmaceuticals and Tribhovandas Bhimji

The main advantage of trading using opposite Emcure Pharmaceuticals and Tribhovandas Bhimji positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emcure Pharmaceuticals position performs unexpectedly, Tribhovandas Bhimji can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tribhovandas Bhimji will offset losses from the drop in Tribhovandas Bhimji's long position.

The idea behind Emcure Pharmaceuticals and Tribhovandas Bhimji Zaveri pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.